⌘K

Login Start Free

Home/Filings/4/0001144204-10-038161

4//SEC Filing

Sung Elsa 4

Accession 0001144204-10-038161

CIK 0001091164other

View on SEC.gov Company Profile

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 1:25 PM ET

Size

13.6 KB

Accession

0001144204-10-038161

Insider Transaction Report

Form 4

Period: 2010-04-21

Jiangbo Pharmaceuticals, Inc.JGBO

Chief Financial Officer

Transactions

Award
Common Stock, par value $0.001
2010-04-21+914→ 1,414 total
Award
Option
2008-06-10+2,000→ 2,000 total
Exercise: $12.00From: 2008-07-01Exp: 2013-06-10→ Common Stock (2,000 underlying)
Award
Option
2008-06-10+1,750→ 3,750 total
Exercise: $16.00From: 2008-12-31Exp: 2013-06-10→ Common Stock (1,750 underlying)
Award
Option
2008-06-10+1,875→ 7,500 total
Exercise: $24.00From: 2009-12-31Exp: 2013-06-10→ Common Stock (1,875 underlying)
Award
Option
2008-06-10+1,875→ 5,625 total
Exercise: $20.00From: 2009-06-30Exp: 2013-06-10→ Common Stock (1,875 underlying)

Footnotes (2)

[F1]No purchase price paid. Shares were issued to the reporting person by the Issuer for services rendered as the Chief Financial Officer of the Issuer.
[F2]Options were issued as part of compensation to the reporting person.

Documents

1 file

4
v190771_ex.xmlPrimary

Issuer

Jiangbo Pharmaceuticals, Inc.

CIK 0001091164

Entity typeother

Related Parties

1

filerCIK 0001414926

Filing Metadata

Form type: 4
Filed: Jul 15, 8:00 PM ET
Accepted: Jul 16, 1:25 PM ET
Size: 13.6 KB

View on SEC.gov